A Foshan-based team identifies Ruminococcus lactaris as a gut bacterium that drives breast cancer progression and chemotherapy resistance via a UDP-GlcNAc-OGT pathway.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.